100 related articles for article (PubMed ID: 25337646)
1. The use of α-fetoprotein for the delivery of cytotoxic payloads to cancer cells.
Pak V
Ther Deliv; 2014 Aug; 5(8):885-92. PubMed ID: 25337646
[TBL] [Abstract][Full Text] [Related]
2. High-efficient expression, refolding and purification of functional recombinant C-terminal fragment of human alpha-fetoprotein.
Sharapova OA; Pozdnykova NV; Laurinavichyute DK; Yurkova MS; Posypanova GA; Fedorov AN; Severin SE; Severin ES
Protein Expr Purif; 2010 Sep; 73(1):31-5. PubMed ID: 20363333
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein-mediated targeting of anti-cancer drugs to tumor cells in vitro.
Severin SE; Moskaleva EYu ; Shmyrev II; Posypanova GA; Belousova YuV ; Sologub VK; Luzhkov YuM ; Nakachian R; Andreani J; Severin ES
Biochem Mol Biol Int; 1995 Oct; 37(2):385-92. PubMed ID: 8673023
[TBL] [Abstract][Full Text] [Related]
4. [Purification and characterization of recombinant human alpha-fetoprotein fragment, corresponding to the C-terminal structural domain].
Sharapova OA; Pozdniakova NV; Laurinavichiute DK; Iurkova MS; Posypanova GA; Andronova SM; Fedorov AN; Severin SE; Severin ES
Bioorg Khim; 2010; 36(6):760-8. PubMed ID: 21317941
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.
Mizejewski GJ; Mirowski M; Garnuszek P; Maurin M; Cohen BD; Poiesz BJ; Posypanova GA; Makarov VA; Severin ES; Severin SE
J Drug Target; 2010 Sep; 18(8):575-88. PubMed ID: 20151941
[TBL] [Abstract][Full Text] [Related]
6. Lipid interactions with human alpha-fetoprotein (AFP). A study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation.
Yachnin S; Getz GS; Lusk L; Hsu RC
Oncodev Biol Med; 1980; 1(4-5):273-85. PubMed ID: 6169064
[TBL] [Abstract][Full Text] [Related]
7. Multiple advantages of alpha-fetoprotein as a marker for in vivo gene transfer.
O'Neal WK; Rose E; Zhou H; Langston C; Rice K; Carey D; Beaudet AL
Mol Ther; 2000 Dec; 2(6):640-8. PubMed ID: 11124066
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of bovine alpha-fetoprotein and comparison with human alpha-fetoprotein.
He Y; Keel BA
Comp Biochem Physiol Biochem Mol Biol; 1994 Jul; 108(3):327-36. PubMed ID: 7521727
[TBL] [Abstract][Full Text] [Related]
9. [Synergic effect of adenoviral vector-encoding human alpha-fetoprotein and interferon-gamma on immunity against hepatocellular carcinoma in mice].
Tan XH; Zhu Q
Ai Zheng; 2008 Feb; 27(2):155-9. PubMed ID: 18279612
[TBL] [Abstract][Full Text] [Related]
10. Human oviductal fluid proteins. V. Identification of human oviductin-I as alpha-fetoprotein.
Wagh PV; Lippes J
Fertil Steril; 1993 Jan; 59(1):148-56. PubMed ID: 7678232
[TBL] [Abstract][Full Text] [Related]
11. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
Butterfield LH; Koh A; Meng W; Vollmer CM; Ribas A; Dissette V; Lee E; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Jul; 59(13):3134-42. PubMed ID: 10397256
[TBL] [Abstract][Full Text] [Related]
12. [Research advances on alpha-fetoprotein physiological function and clinical potential].
Yin ZF; Wang CH
Ai Zheng; 2003 Jan; 22(1):108-11. PubMed ID: 12561448
[TBL] [Abstract][Full Text] [Related]
13. Recombinant alpha-fetoprotein C-terminal fragment: the new recombinant vector for targeted delivery.
Posypanova GA; Gorokhovets NV; Makarov VA; Savvateeva LV; Kireeva NN; Severin SE; Severin ES
J Drug Target; 2008 May; 16(4):321-8. PubMed ID: 18446611
[TBL] [Abstract][Full Text] [Related]
14. A new system for targeted delivery of doxorubicin into tumor cells.
Yabbarov NG; Posypanova GA; Vorontsov EA; Obydenny SI; Severin ES
J Control Release; 2013 Jun; 168(2):135-41. PubMed ID: 23517785
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
Pang XH; Chen MS; Jia WH; Zhou XX
Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic action of conjugates of alpha-fetoprotein and epidermal growth factor with photoheme, chlorines, and phthalocyanines.
Savitsky AA; Gukasova NV; Gumanov SG; Feldman NB; Luk'yanets EA; Mironov AF; Yakubovskaya RI; Lutsenko SV; Severin SE
Biochemistry (Mosc); 2000 Jun; 65(6):732-6. PubMed ID: 10887296
[TBL] [Abstract][Full Text] [Related]
17. Modeling of three dimensional structure of human alpha-fetoprotein complexed with diethylstilbestrol: docking and molecular dynamics simulation study.
Terentiev AA; Moldogazieva NT; Levtsova OV; Maximenko DM; Borozdenko DA; Shaitan KV
J Bioinform Comput Biol; 2012 Apr; 10(2):1241012. PubMed ID: 22809347
[TBL] [Abstract][Full Text] [Related]
18. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
Mizejewski GJ
Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
[TBL] [Abstract][Full Text] [Related]
19. The receptor binding fragment of alpha-fetoprotein is a promising new vector for the selective delivery of antineoplastic agents.
Posypanova GA; Makarov VA; Savvateeva MV; Bereznikova AV; Severin ES
J Drug Target; 2013 May; 21(5):458-65. PubMed ID: 23600748
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation.
Yachnin S; Lester EP
J Immunol; 1977 Aug; 119(2):555-7. PubMed ID: 69662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
